10X Gene Editing Power Unlocked! New AI Breakthrough Revealed! #shorts #ai #biology

Profluent AI enables 10X expansion of actionable mutations for base editing, surpassing current SpCas9 limitations. This significantly broadens the addressable market and patient pool. #GeneEditing #AIinBiotech Profluent just signed a $2.25B partnership with Eli Lilly to develop AI-designed gene editors - one of the largest deals to date between a frontier AI biology lab and big pharma. It capped a huge few weeks for AI in bio, alongside Verve's base-editing data, new scaling results on protein models, and Isomorphic Labs' latest raise. Profluent: https://www.profluent.bio Air Street Capital: https://www.airstreet.com Follow Ali: https://x.com/thisismadani Follow Nathan: https://x.com/nathanbenaich